A Meta‐Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAX

By Eugene V. McCloskey, A. Odén, Nicholas C. Harvey, William D. Leslie, D. Hans, H. Johansson, R. Barkmann, S. Boutroy, Jacques P. Brown, R. Chapurlat and 26 more. Journal of Bone and Mineral Research, 2016

671 citations recorded by the source corpus.

Subfields: Orthopedics and Sports Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/1321f2e57208d287635e50f79ce6d052448a2462

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Orthopedics and Sports Medicine

1. Chris Cooper
2. J. Reginster
3. R. Rizzoli
4. Eugene V. McCloskey
5. on behalf of the International Osteoporosis Foundation
6. J. Kanis
7. Nicholas C. Harvey
8. H. Johansson

In Surgery

1. Chris Cooper
2. J. Reginster
3. Eugene V. McCloskey
4. R. Rizzoli
5. J. Kanis
6. on behalf of the International Osteoporosis Foundation
7. Nicholas C. Harvey
8. H. Johansson

Citations in the corpus

• UK clinical guideline for the prevention and treatment of osteoporosis (2017, background): “TBS values can be entered on the UK FRAX website.”
• European guidance for the diagnosis and management of osteoporosis in postmenopausal women (2018, methodology): “concurrent data on lumbar spine BMD [101, 102]—see below trabecular bone score [77, 80, 81, 103] hip axis length [104] falls history [105] immigration status [106] type 2 diabetes [68, 107]”
• The clinician’s guide to prevention and treatment of osteoporosis (2022, background): “TBS is FDA approved and provides additional utility in fracture risk assessment among people with secondary causes of bone loss and fractures, such as type 2 diabetes [83, 86, 87].”